About
Botanical Drug for Smoking Cessation
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
352
By Phase
PHASE2: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06091826Lead Sponsor
Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO)
PHASE2Completed
34 participants
Started: Feb 21, 2023 · Completed: Sep 30, 2023
NCT04571216Lead Sponsor
Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy
PHASE2Completed
318 participants
Started: Apr 12, 2021 · Completed: Apr 12, 2024
Locations (1)
Headquarters
Montpellier, France
Map
Loading map...